Condensed Consolidated Balance Sheets (Unaudited) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014		Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 118,258	[1]	$ 185,798	[1]
Accounts receivable, net	21,210	[1]	19,767	[1]
Inventory, net	16,662	[1]	18,079	[1]
Prepaid expenses and other current assets	7,018	[1]	19,084	[1]
Total current assets	163,148	[1]	242,728	[1]
Property, plant, equipment, and investment properties, net	17,036	[1]	17,027	[1]
Intangible assets, net	65,553	[1]	74,533	[1]
In-process research and development	793,214	[1]	793,341	[1]
Goodwill	224,769	[1]	226,373	[1]
Investments, net	26,849	[1]	30,653	[1]
Other assets	4,673	[1]	6,861	[1]
Total assets	1,295,242	[1]	1,391,516	[1]
Current liabilities:
Accounts payable	8,841	[1]	13,414	[1]
Accrued expenses	55,554	[1]	65,874	[1]
Current portion of lines of credit and notes payable	12,446	[1]	12,562	[1]
Total current liabilities	76,841	[1]	91,850	[1]
2033 Senior Notes, net of discount and estimated fair value of embedded derivatives	114,883	[1]	211,912	[1]
Other long-term liabilities, principally contingent consideration and deferred tax liabilities	216,174	[1]	214,775	[1]
Total long-term liabilities	331,057	[1]	426,687	[1]
Total liabilities	407,898	[1]	518,537	[1]
Equity:
Common Stock - $0.01 par value, 750,000,000 shares authorized; 432,895,788 and 414,818,195 shares issued at September 30, 2014 and December 31, 2013, respectively	4,329	[1]	4,148	[1]
Treasury Stock - 1,245,367 and 2,264,063 shares at September 30, 2014 and December 31, 2013, respectively	(4,051)	[1]	(7,362)	[1]
Additional paid-in capital	1,523,548	[1]	1,379,383	[1]
Accumulated other comprehensive income (loss)	(8,697)	[1]	3,418	[1]
Accumulated deficit	(621,872)	[1]	(503,177)	[1]
Total shareholders’ equity attributable to OPKO	893,257	[1]	876,410	[1]
Noncontrolling interests	(5,913)	[1]	(3,431)	[1]
Total shareholders’ equity	887,344	[1]	872,979	[1]
Total liabilities and equity	$ 1,295,242	[1]	$ 1,391,516	[1]

[1] As of September 30, 2014 and December 31, 2013, total assets include $7.4 million and $6.7 million, respectively, and total liabilities include $13.1 million and $10.4 million, respectively, related to SciVac Ltd (“SciVac”), previously known as SciGen (I.L.) Ltd, a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and SciVac’s consolidated liabilities have no recourse against us. Refer to Note 5.